Inventor · disambiguated record
Joseph Arndt
Also filed as: ARNDT JOSEPH · ARNDT JOSEPH W · ARNDT JOSEPH WALTER
6 granted patents·9 pending applications·12 citations·filing 1998–2024
76Inventor score
Files withBIOGEN MA INC5SUNESIS PHARMACEUTICALS INC3VIRACTA THERAPEUTICS INC2ABBOTT LAB1ARNDT JOSEPH1
Top patents by PatentIndex Score
15 records- 0184US2024294524A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0280US10030016B2Heterocyclic compounds useful as PDK1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 24, 2018·2 cites·16 claims
- 0377US2023113598A1Heterocyclic compounds useful as pdk1 inhibitorsVIRACTA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0473US12162952B2Human-derived anti-(poly-GA) dipeptide repeat (DPR) antibodyBIOGEN MA INC·Filed 2019·Granted Dec 10, 2024·1 cites·18 claims
- 0570US9546165B2Heterocyclic compounds useful as PDK1 inhibitorsARNDT JOSEPH·Filed 2010·Granted Jan 17, 2017·2 cites·12 claims
- 0670US2021070752A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0768US12037398B2Anti-VLA-4 antibodies having reduced effector functionBIOGEN MA INC·Filed 2019·Granted Jul 16, 2024·1 cites·42 claims
- 0863US2019119268A1Heterocyclic compounds useful as pdk1 inhibitorsSUNESIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 0959US2012003235A1Anti-lymphotoxin antibodiesRANGER ANN M·Filed 2009·Application pending·0 cites
- 1057US2025041385A1Modified actrii proteins and methods of use thereofBIOGEN MA INC·Filed 2022·Application pending·0 cites
- 1148US2014079716A1Anti-lymphotoxin antibodiesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1245US9567392B2JCV neutralizing antibodiesBIOGEN MA INC·Filed 2013·Granted Feb 14, 2017·0 cites·12 claims
- 1343US6080844AProcess for the recovery and purification of a recombinant protein from a cellABBOTT LAB·Filed 1998·Granted Jun 27, 2000·6 cites·5 claims
- 1439US2020270335A1Dkk2 cysteine rich domain 2 containing proteins and uses thereofBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 1537US2015315267A1A method of reducing brain amyloid plaques using anti-ab antibodiesBUSSIERE THIERRY·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph Arndt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →